Haemonetics Corp. HAE

NYS: HAE | ISIN: US4050241003   2/06/2023
88,13 USD (+1,80%)
(+1,80%)   2/06/2023

11 mei 2023 · Haemonetics 4th Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website · Persbericht

25 april 2023 · Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2023 Results: May 11, 2023 · Persbericht

20 april 2023 · Haemonetics Publishes Inaugural Corporate Responsibility Report · Persbericht

2 maart 2023 · Haemonetics Introduces Next Generation "Intelligent Control" Software for Cell Saver® Elite®+ Autotransfusion System · Persbericht

27 februari 2023 · Haemonetics to Present at Raymond James 44th Annual Institutional Investors Conference · Persbericht

7 februari 2023 · Haemonetics 3rd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website · Persbericht

6 januari 2023 · Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2023 Results: February 7, 2023 · Persbericht

19 december 2022 · Haemonetics to Present at 41st Annual J.P. Morgan Healthcare Conference · Persbericht

7 november 2022 · Haemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website · Persbericht

6 oktober 2022 · Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2023 Results: November 7, 2022 · Persbericht

4 oktober 2022 · Haemonetics Appoints Roy Galvin as President, Global Plasma and Blood Center · Persbericht

12 september 2022 · Haemonetics Earns CE Mark for VASCADE® Vascular Closure Product Portfolio · Persbericht

29 augustus 2022 · Haemonetics Announces Agreement to Offer Enhanced Transfusion Management Software to Epic's Global Network of Hospitals · Persbericht

24 augustus 2022 · Haemonetics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference · Persbericht

10 augustus 2022 · Haemonetics 1st Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website · Persbericht

7 juli 2022 · Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2023 Results: August 10, 2022 · Persbericht

24 juni 2022 · Haemonetics Completes Move to New Manufacturing Facility in Clinton, PA · Persbericht

6 juni 2022 · Haemonetics Corporation Announces Additional Information Regarding Its Investor Day on June 29, 2022 · Persbericht

10 mei 2022 · Haemonetics 4th Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website · Persbericht

10 mei 2022 · Haemonetics to Host Investor Day Event on June 29, 2022 · Persbericht

Mijn selecties